Switch theme
Sign up to access all valuation multiples
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales.
1969
4.4K+
LTM Revenue $1.6B
LTM EBITDA $324M
$3.0B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Integra Lifesciences has a last 12-month revenue of $1.6B and a last 12-month EBITDA of $324M.
In the most recent fiscal year, Integra Lifesciences achieved revenue of $1.6B and an EBITDA of $193M.
Integra Lifesciences expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Integra Lifesciences valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $1.5B | $1.6B | XXX | XXX | XXX |
| Gross Profit | $970M | $885M | XXX | XXX | XXX |
| Gross Margin | 63% | 55% | XXX | XXX | XXX |
| EBITDA | $256M | $193M | XXX | XXX | XXX |
| EBITDA Margin | 17% | 12% | XXX | XXX | XXX |
| Net Profit | $181M | $67.7M | XXX | XXX | XXX |
| Net Margin | 12% | 4% | XXX | XXX | XXX |
| Net Debt | $987M | $1.2B | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Integra Lifesciences's stock price is $17.
Integra Lifesciences has current market cap of $1.3B, and EV of $3.0B.
See Integra Lifesciences trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $3.0B | $1.3B | XXX | XXX | XXX | XXX | $2.53 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Integra Lifesciences has market cap of $1.3B and EV of $3.0B.
Integra Lifesciences's trades at 1.8x LTM EV/Revenue multiple, and 9.3x LTM EBITDA.
Analysts estimate Integra Lifesciences's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Integra Lifesciences and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $3.0B | XXX | XXX | XXX |
| EV/Revenue | 1.9x | XXX | XXX | XXX |
| EV/EBITDA | 15.5x | XXX | XXX | XXX |
| P/E | -186.1x | XXX | XXX | XXX |
| P/E/Growth | n/a | XXX | XXX | XXX |
| EV/FCF | 200.1x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpIntegra Lifesciences's NTM/LTM revenue growth is 4%
Integra Lifesciences's revenue per employee for the last fiscal year averaged $0.4M, while opex per employee averaged $0.2M for the same period.
Over next 12 months, Integra Lifesciences's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Integra Lifesciences's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Integra Lifesciences and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 4% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 12% | XXX | XXX | XXX | XXX |
| EBITDA Growth | -24% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | 16% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.4M | XXX | XXX | XXX | XXX |
| Opex per Employee | $0.2M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | 7% | XXX | XXX | XXX | XXX |
| Opex to Revenue | 53% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Integra Lifesciences acquired XXX companies to date.
Last acquisition by Integra Lifesciences was XXXXXXXX, XXXXX XXXXX XXXXXX . Integra Lifesciences acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Integra Lifesciences founded? | Integra Lifesciences was founded in 1969. |
| Where is Integra Lifesciences headquartered? | Integra Lifesciences is headquartered in United States of America. |
| How many employees does Integra Lifesciences have? | As of today, Integra Lifesciences has 4.4K+ employees. |
| Who is the CEO of Integra Lifesciences? | Integra Lifesciences's CEO is Ms. Mojdeh Poul. |
| Is Integra Lifesciences publicy listed? | Yes, Integra Lifesciences is a public company listed on NAS. |
| What is the stock symbol of Integra Lifesciences? | Integra Lifesciences trades under IART ticker. |
| When did Integra Lifesciences go public? | Integra Lifesciences went public in 1995. |
| Who are competitors of Integra Lifesciences? | Similar companies to Integra Lifesciences include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of Integra Lifesciences? | Integra Lifesciences's current market cap is $1.3B |
| What is the current revenue of Integra Lifesciences? | Integra Lifesciences's last 12-month revenue is $1.6B. |
| What is the current EBITDA of Integra Lifesciences? | Integra Lifesciences's last 12-month EBITDA is $324M. |
| What is the current EV/Revenue multiple of Integra Lifesciences? | Current revenue multiple of Integra Lifesciences is 1.8x. |
| What is the current EV/EBITDA multiple of Integra Lifesciences? | Current EBITDA multiple of Integra Lifesciences is 9.3x. |
| What is the current revenue growth of Integra Lifesciences? | Integra Lifesciences revenue growth between 2023 and 2024 was 4%. |
| Is Integra Lifesciences profitable? | Yes, Integra Lifesciences is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
